Канал: IMI PREFER

PREFER Recommendations webinar

PREFER Recommendations webinar

Webinar on the EMA qualification opinion of PREFER

Webinar on the EMA qualification opinion of PREFER

Patient preferences in diabetes

Patient preferences in diabetes

Patient preferences in multiple myeloma

Patient preferences in multiple myeloma

PREFER Educational tools | Informing preferences for 2-line treatment assessed in patients with RA

PREFER Educational tools | Informing preferences for 2-line treatment assessed in patients with RA

Patient preferences for the treatment of chronic pain

Patient preferences for the treatment of chronic pain

Methods for patient preference studies: what to use when

Methods for patient preference studies: what to use when

PREFER webinar on areas of future research in patient preferences

PREFER webinar on areas of future research in patient preferences

Antithrombotic treatment during and following a heart attack - Cathy Anne Pinto & Tommi Tervonen

Antithrombotic treatment during and following a heart attack - Cathy Anne Pinto & Tommi Tervonen

PREFER webinar on patient preferences for non-small-cell lung cancer treatment options

PREFER webinar on patient preferences for non-small-cell lung cancer treatment options

Patient preferences for non-small-cell lung cancer treatment: A qualitative study - Rosanne Janssens

Patient preferences for non-small-cell lung cancer treatment: A qualitative study - Rosanne Janssens

Patient preferences for non-small-cell lung cancer treatment: A quantitative study - Serena Oliveri

Patient preferences for non-small-cell lung cancer treatment: A quantitative study - Serena Oliveri

Use of educational tools: Experience from the PREFER lung cancer case study - Meredith Smith

Use of educational tools: Experience from the PREFER lung cancer case study - Meredith Smith

PREFER, patient preferences & the lung cancer case study - Isabelle Huys & Serena Oliveri

PREFER, patient preferences & the lung cancer case study - Isabelle Huys & Serena Oliveri

Preferences for treatments to prevent rheumatoid arthritis (RA) - Marie Falahee | PREFER webinar

Preferences for treatments to prevent rheumatoid arthritis (RA) - Marie Falahee | PREFER webinar

Patient involvement in the RA case studies – Gwenda Simons & Eva Johansson | PREFER webinar

Patient involvement in the RA case studies – Gwenda Simons & Eva Johansson | PREFER webinar

An introduction to rheumatoid arthritis - Karim Raza | PREFER webinar

An introduction to rheumatoid arthritis - Karim Raza | PREFER webinar

Patients' preference for second line RA treatment - Karin Schölin Bywall | PREFER webinar

Patients' preference for second line RA treatment - Karin Schölin Bywall | PREFER webinar

Patient Preferences in Rheumatoid Arthritis | PREFER webinar

Patient Preferences in Rheumatoid Arthritis | PREFER webinar

The importance of different symptoms to people living with chronic obstructive pulmonary disease

The importance of different symptoms to people living with chronic obstructive pulmonary disease

PREFER | Public consultation 15 October - 25 November

PREFER | Public consultation 15 October - 25 November

PREFER webinar on the PAVING study as an IMI PREFER case study

PREFER webinar on the PAVING study as an IMI PREFER case study

PAVING study results and conclusions - Eline van Overbeeke | PREFER webinar

PAVING study results and conclusions - Eline van Overbeeke | PREFER webinar

Design of the PAVING study - Brett Hauber | PREFER webinar

Design of the PAVING study - Brett Hauber | PREFER webinar

Introduction to the decision making and clinical studies & objectives: Isabelle Huys, PREFER webinar

Introduction to the decision making and clinical studies & objectives: Isabelle Huys, PREFER webinar

Application of preference data to inform regulatory decision-making- Bennett Levitan |PREFER webinar

Application of preference data to inform regulatory decision-making- Bennett Levitan |PREFER webinar

Introduction to the PREFER framework & what we’d like this to achieve- Conny Berlin | PREFER webinar

Introduction to the PREFER framework & what we’d like this to achieve- Conny Berlin | PREFER webinar

How the PREFER framework addresses the study purpose - Kristin Bullok | PREFER webinar

How the PREFER framework addresses the study purpose - Kristin Bullok | PREFER webinar

Application of preference data to inform HTA decision-making - Irina Cleemput | PREFER webinar

Application of preference data to inform HTA decision-making - Irina Cleemput | PREFER webinar

Points to consider for method selection - Brett Hauber | PREFER webinar

Points to consider for method selection - Brett Hauber | PREFER webinar

PREFER webinar on designing and applying results from patient preference studies

PREFER webinar on designing and applying results from patient preference studies

What is a patient preference? στα ελληνικα

What is a patient preference? στα ελληνικα

What is a patient preference? En español

What is a patient preference? En español

What is a patient preference? En català

What is a patient preference? En català

What is a patient preference? In limba romana

What is a patient preference? In limba romana

What is a patient preference? En français

What is a patient preference? En français

PREFER webinar on the PREFER Research Agenda

PREFER webinar on the PREFER Research Agenda

PREFER - In italiano

PREFER - In italiano

PREFER - Po slovensky

PREFER - Po slovensky

PREFER - En español

PREFER - En español

PREFER - En català

PREFER - En català

PREFER - En français

PREFER - En français

Patient experience in PREFER - RA case study - Marie Falahee | PREFER webinar

Patient experience in PREFER - RA case study - Marie Falahee | PREFER webinar

PREFER webinar on Patient involvement in patient preference studies

PREFER webinar on Patient involvement in patient preference studies

Patient involvement in conduct of patient preference study - Rosanne Janssens | PREFER webinar

Patient involvement in conduct of patient preference study - Rosanne Janssens | PREFER webinar

Patient involvement in design of patient preference study - Eline van Overbeeke| PREFER webinar

Patient involvement in design of patient preference study - Eline van Overbeeke| PREFER webinar

What are patient preferences? - Isabelle Huys | PREFER webinar

What are patient preferences? - Isabelle Huys | PREFER webinar

Key lessons from patients - Antonella Cardone | PREFER webinar

Key lessons from patients - Antonella Cardone | PREFER webinar

Patient involvement in communication in patient preference study - Meredith Smith | PREFER webinar

Patient involvement in communication in patient preference study - Meredith Smith | PREFER webinar

Stakeholders' needs towards patient preference studies - Rosanne Janssens | PREFER webinar

Stakeholders' needs towards patient preference studies - Rosanne Janssens | PREFER webinar

Value of patient preferences in HTA/payer decision-making - Irina Cleemput | PREFER webinar

Value of patient preferences in HTA/payer decision-making - Irina Cleemput | PREFER webinar

Patient preferences in regulatory decisions - Mireille Muller & Monika Brand | PREFER webinar

What are patient preferences - Isabelle Huys | PREFER webinar

What are patient preferences - Isabelle Huys | PREFER webinar

PREFER webinar on patient preferences in drug development and evaluation

PREFER webinar on patient preferences in drug development and evaluation

PREFER | Seasons greetings 2020!

PREFER | Seasons greetings 2020!

Isabelle Huys at Patient Engagement Open Forum | PREFER

Isabelle Huys at Patient Engagement Open Forum | PREFER

PREFER | Lung cancer

PREFER | Lung cancer

PREFER and Neuromuscular Disorders

PREFER and Neuromuscular Disorders

PREFER | Happy Holidays!

PREFER | Happy Holidays!

PREFER | Achievements: first two years

PREFER | Achievements: first two years

PREFER | Rheumatoide arthritis (in German)

PREFER | Rheumatoide arthritis (in German)

PREFER | Rheumatoid arthritis

PREFER | Rheumatoid arthritis

PREFER: Whose preferences are we collecting?

PREFER: Whose preferences are we collecting?

PREFER: Why we need a Public-Private partnership

PREFER: Why we need a Public-Private partnership

PREFER webinar: Eliciting Patients’ Preferences for Parkinson’s Devices

PREFER webinar: Eliciting Patients’ Preferences for Parkinson’s Devices

Giving patients a voice in drug development (PREFER)

Giving patients a voice in drug development (PREFER)

What is a patient preference?

What is a patient preference?